Indiana University–Purdue University Indianapolis, commonly referred to as IUPUI, is a public research university in Indianapolis, Indiana. It is a collaboration between Indiana University and Purdue University that offers undergraduate, graduate, and professional degrees from both systems.

During the past decade, Indiana University conducted 351 clinical trials. In the 10-year time frame, 351 clinical trials started and 202 clinical trials were completed, i.e. on average, 57.5% percent of trials that started reached the finish line to date. In the past 5 years, 152 clinical trials started and 111 clinical trials were completed. i.e. 73% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indiana University" #1 sponsor was "Indiana University" with 101 trials, followed by "NICHD Neonatal Research Network" with 44 trials sponsored, "Gilead Sciences" with 11 trials sponsored, "Celgene" with 10 trials sponsored and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 10 trials sponsored. Other sponsors include 449 different institutions and companies that sponsored additional 255 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana University" #1 collaborator was "National Center for Research Resources (NCRR)" with 37 trials as a collaborator, "Indiana University" with 34 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 30 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 24 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 23 trials as a collaborator. Other collaborators include 676 different institutions and companies that were collaborators in the rest 360 trials.

According to Clinical.Site data, the most researched conditions in "Indiana University" are "Infant, Newborn" (39 trials), "Infant, Small for Gestational Age" (30 trials), "Infant, Premature" (27 trials), "Infant, Low Birth Weight" (25 trials) and "Cystic Fibrosis" (20 trials). Many other conditions were trialed in "Indiana University" in a lesser frequency.

Most popular intervention types in "Indiana University" are "Drug" (325 trials), "Device" (102 trials), "Other" (81 trials), "Procedure" (45 trials) and "Behavioral" (41 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (96 trials), "IVA" (7 trials), "Standard of Care" (7 trials), "ELX/TEZ/IVA" (5 trials) and "Gemcitabine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Indiana University" are 568 trials for "All" genders, 49 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are 180 active trials in "Indiana University". 6 are not yet recruiting, 119 are recruiting, 46 are Active, not recruiting, and 9 are Enrolling by invitation. In total, there were 350 completed trials in Indiana University, 3 suspended trials, and 69 terminated clinical trials to date.

Out of the total trials that were conducted in Indiana University, 44 "Phase 1" clinical trials were conducted, 164 "Phase 2" clinical trials and 137 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 25 trials, and there were also 155 trials that are defined as “Not Applicable".

Indiana University has several departments that took part in Clinical trials: "Indiana University School of Nursing" - 11 trials, "IUPUI Department of Psychology" - 2 trials